Stories from The University of Texas Health Science Center at Houston (UTHealth Houston)
September 27, 2022
Populations in U.S. counties defined as more vulnerable based on social factors including socioeconomic status and racial/ethnic minority status were significantly less likely to receive timely breast, cervical, and colorectal cancer screenings, according to research from UTHealth Houston.
September 22, 2022
A four-year, $1.2 million grant that will help create a vaccine knowledge base has been given to researchers at UTHealth Houston, which is a subcontractor on a larger, $3.7 million grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID).
September 22, 2022
A five-year, nearly $5 million grant, which will help create a coordinating unit for biostatistics, informatics, and engagement (CUBIE) for a Cell Atlas Network program to advance knowledge about the interacting neurons of the human brain, has been awarded to researchers at UTHealth Houston by the National Institutes of Health (NIH) Brain Research Through Advancing Neurotechnologies (BRAIN) Initiative.
September 20, 2022
Adolescent and young adult women who were diagnosed with cancer and received chemotherapy treatment prior to pregnancy did not have a higher risk of stillbirth, according to research led by Caitlin C. Murphy, PhD, MPH, with UTHealth Houston.
September 19, 2022
Adolescents suffering with severe obesity who underwent bariatric surgery before the age of 22 had significant and lasting reductions in weight and comorbidities after surgery, according to researchers from UTHealth Houston and the University of Miami.
September 15, 2022
Having experienced a stroke less than three hours before being admitted to the hospital, Andrea Arsimendez qualified for the Multi-arm Optimization of Stroke Thrombolysis (MOST) clinical trial at UTHealth Houston, which is investigating which blood thinner – argatroban or epitifibatide – improves recovery among acute ischemic stroke patients treated with standard-of-care thrombolysis within three hours of symptom onset.
September 9, 2022
As part of the celebration of its golden anniversary, guests representing the past, present, and future of Cizik School of Nursing gathered near the school’s main entrance on Wednesday, Sept. 7, to open a time capsule filled with treasures from 2007.
September 7, 2022
A newly developed agonistic antibody reduced the amyloid pathology in mice with Alzheimer’s disease, signaling its promise as a potential treatment for the disease, according to a team of researchers at UTHealth Houston.
September 2, 2022
Katherine Loveland, PhD, with McGovern Medical School at UTHealth Houston, received a grant from the Health Resources and Services Administration to train psychology interns in substance use disorder (SUD) and opioid use disorder (OUD) trauma, and telehealth with underserved communities.
September 1, 2022
By comparing the risk of the first aortic surgical or medical event for patients with the gene mutation they carry, researchers with UTHealth Houston were able to tell which of seven common genes associated with thoracic aortic disease were more likely to lead to earlier, aggressive disease and death.
Use the form below to perform a new search.